Perform Recommendation Issued On QNCX By Citigroup

January 30, 2026 01:15:03 am

Source: KlickAnalytics

2026-01-30 01:15:03 ET

Citigroup analyst issues PERFORM recommendation for QNCX on January 30, 2026 05:59AM ET.

The previous analyst recommendation was Market Perform.

QNCX was trading at $0.2701 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 3 - Buy, 3 - Hold, 2 - Sell recommendations .

Quince Therapeutics Inc.

5.64% G/L:

$1.2149 Last:

390,515 Volume:

$1.175 Open:

April 08, 2026 10:16:06 am

March 30, 2026 08:30:00 am

February 11, 2026 09:46:31 am

February 09, 2026 04:05:00 pm

Market Cap$29,383,122

Float44,378,148

Insiders Ownership0.16%

Institutions25

Short PercentN/A

IndustryBiotechnology & Life Sciences

SectorHealthcare

CountryUS

CitySouth San Francisco